Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.60 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1489409 | 0.87 | L3MBTL1 (0.66) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL24569513 | 0.84 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL29888172 | 0.81 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL24570249 | 0.81 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL29887959 | 0.81 | PDE7A (0.55) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL24569515 | 0.81 | PDE7A (0.55) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL19911367 | 0.81 | ALDH1A1 (0.57) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL19911366 | 0.80 | PKM (0.68) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL19911364 | 0.80 | MAPT (0.61) | L3MBTL1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL594361 | 0.80 | ALDH1A1 (0.60) | L3MBTL1ALDH1A1MAPTPKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3404056-B1 | METHOD FOR PRODUCING THERMOPLASTIC ELASTOMER COMPOSITION | ZEON CORP (JP) | 2025-06-11 | — | — | EP | disclosed |
| EP-3101065-B1 | CROSS-LINKABLE NITRILE RUBBER COMPOSITION AND CROSS-LINKED RUBBER | ZEON CORP (JP) | 2025-05-28 | — | — | EP | disclosed |
| US-12202923-B2 | Nitrile-group-containing copolymer rubber | ZEON CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| US-12037636-B2 | Polynucleotide synthesis method, kit and system | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-07-16 | — | — | US | disclosed |
| CN-114555660-B | Nitrile group-containing copolymer rubber | 日本瑞翁株式会社 | 2024-06-11 | — | — | CN | disclosed |
| EP-3305817-B2 | NITRILE GROUP CONTAINING, HIGHLY SATURATED COPOLYMER RUBBER | ZEON CORP (JP) | 2023-12-27 | — | — | EP | disclosed |
| EP-3744739-B1 | METHOD FOR PRODUCING CARBOXY GROUP-CONTAINING HYDROGENATED NITRILE RUBBER | ZEON CORP (JP) | 2023-12-27 | — | — | EP | disclosed |
| US-11639408-B2 | Nitrile group-containing copolymer rubber | ZEON CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-3604433-B1 | CROSSLINKABLE RUBBER COMPOSITION AND CROSSLINKED RUBBER OBJECT | ZEON CORP (JP) | 2023-04-19 | — | — | EP | disclosed |
| EP-3176190-B1 | NITRILE-GROUP-CONTAINING COPOLYMER RUBBER, CROSSLINKABLE RUBBER COMPOSITION, AND CROSSLINKED RUBBER | ZEON CORP (JP) | 2023-03-29 | — | — | EP | disclosed |
| US-7253204-B2 | Antiproliferative agents | METHYLGENE INC. (CA) | 2007-08-07 | — | — | US | disclosed |
| US-7253204-B2 | Antiproliferative agents | METHYLGENE INC. (CA) | 2007-08-07 | — | — | US | disclosed |
| WO-2007016354-A1 | MULTICYCLIC SULFONAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070027184-A1 | Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease | KALYPSYS, INC. | 2007-02-01 | — | — | US | disclosed |
| EP-1735319-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2006-12-27 | — | — | EP | disclosed |
| WO-2006123145-A1 | ANTIFUNGAL AGENTS | F2G LTD (GB) | 2006-11-23 | — | — | WO | disclosed |
| US-20050245518-A1 | Antiproliferative agents | METHYLGENE, INC. | 2005-11-03 | — | — | US | disclosed |
| WO-2005092899-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005092899-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005035526-A1 | BICYCLIC COMPOUNDS AND THEIR THERAPEUTIC USE | ARGENTA DISCOVERY LTD. (GB) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027184-A1 | Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease | HDAC6, HDAC5, HDAC7 | L3MBTL1 3403/4885ALDH1A1 1241/4885MAPT 1682/4885 |
| US-20050245518-A1 | Antiproliferative agents | HDAC1, HDAC11, HDAC5 | L3MBTL1 1607/4885ALDH1A1 758/4885MAPT 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.